Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Häring MF"'
Autor:
Thomas Rathjen, Häring Mf, Monica M. Bertagnolli, Lars Melholt Rasmussen, Christian Rask-Madsen, Xuanchun Wang, Siegfried Ussar, Ditte Sørensen, Samuel M. Lockhart, Kahn Cr
Publikováno v:
Oncogene 36, 4987-4996 (2017)
Oncogene
Wang, X, Häring, M-F, Rathjen, T, Lockhart, S M, Sørensen, D, Ussar, S, Rasmussen, L M, Bertagnolli, M M, Kahn, C R & Rask-Madsen, C 2017, ' Insulin resistance in vascular endothelial cells promotes intestinal tumour formation ', Oncogene, vol. 36, no. 35, pp. 4987–4996 . https://doi.org/10.1038/onc.2017.107
Oncogene
Wang, X, Häring, M-F, Rathjen, T, Lockhart, S M, Sørensen, D, Ussar, S, Rasmussen, L M, Bertagnolli, M M, Kahn, C R & Rask-Madsen, C 2017, ' Insulin resistance in vascular endothelial cells promotes intestinal tumour formation ', Oncogene, vol. 36, no. 35, pp. 4987–4996 . https://doi.org/10.1038/onc.2017.107
The risk of several cancers, including colorectal cancer, is increased in patients with obesity and type 2 diabetes, conditions characterised by hyperinsulinaemia and insulin resistance. Because hyperinsulinaemia itself is an independent risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba6d6ec1573a0c2e119962588be65c08
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=51867
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=51867
Autor:
Nelde A; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Schuster H; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany., Heitmann JS; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Bauer J; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Maringer Y; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Zwick M; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Volkmer JP; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California., Chen JY; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California., Stanger AMP; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland., Lehmann A; Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany., Appiah B; Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany., Märklin M; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Rücker-Braun E; Department of Medicine I, University Hospital of Dresden, Dresden, Germany.; Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany., Salih HR; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Roerden M; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Schroeder SM; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, University of Tübingen, Tübingen, Germany., Häring MF; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Schlosser A; Rudolf-Virchow-Zentrum, University Würzburg, Würzburg, Germany., Schetelig J; Department of Medicine I, University Hospital of Dresden, Dresden, Germany.; German Bone Marrow Donor Center (DKMS), Clinical Trials Unit, Dresden, Germany., Schmitz M; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; German Cancer Consortium (DKTK), partner site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Boerries M; Faculty of Medicine, Medical Center, Institute of Medical Bioinformatics and Systems Medicine (IBSM), University of Freiburg, Germany.; Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site, Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Köhler N; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Centre for Integrative Biological Signalling Studies (CIBSS), University of Freiburg, Freiburg, Germany., Lengerke C; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.; Department of Biomedicine, University of Basel and University Hospital Basel, Basel, Switzerland.; Clinic for Hematology, University of Basel and University Hospital Basel, Basel, Switzerland.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Germany., Majeti R; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California.; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California., Weissman IL; Institute for Stem Cell Biology and Regenerative Medicine and the Ludwig Cancer Center, Stanford University School of Medicine, Stanford, California., Rammensee HG; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Germany., Walz JS; Department of Peptide-Based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany.; Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
Publikováno v:
Blood cancer discovery [Blood Cancer Discov] 2023 Nov 01; Vol. 4 (6), pp. 468-489.
Autor:
Mix L; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Knoll M; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Häring MF; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Bethge WA; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Schröder JC; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Forchhammer S; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Krumm P; Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Tübingen, Germany., Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany., Schaller M; Department of Dermatology, University Hospital Tübingen, Tübingen, Germany., Lengerke C; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Aug 16; Vol. 13, pp. 1218517. Date of Electronic Publication: 2023 Aug 16 (Print Publication: 2023).
Autor:
Häring MF, Lengerke C
Publikováno v:
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2022 Oct; Vol. 147 (20), pp. 1342-1354. Date of Electronic Publication: 2022 Oct 04.
Autor:
Häntschel M; Department of Internal Medicine VIII, Medical Oncology and Pneumology, Eberhard Karls University, Tübingen, Germany., Niebling J; Department of Internal Medicine II, Oncology, Hematology, Clinical Immunology and Rheumatology, Eberhard Karls University, Tübingen, Germany., Häring A; Department of Internal Medicine II, Oncology, Hematology, Clinical Immunology and Rheumatology, Eberhard Karls University, Tübingen, Germany., Häring MF; Department of Internal Medicine II, Oncology, Hematology, Clinical Immunology and Rheumatology, Eberhard Karls University, Tübingen, Germany., Groß T; Department of Internal Medicine VIII, Medical Oncology and Pneumology, Eberhard Karls University, Tübingen, Germany., Horger M; Department of Radiology, University Hospital and Comprehensive Cancer Center Tübingen, Eberhard Karls University, Tübingen, Germany., Riessen R; Department of Internal Medicine, Medical Intensive Care Unit, Eberhard Karls University, Tübingen, Germany., Haap M; Department of Internal Medicine, Medical Intensive Care Unit, Eberhard Karls University, Tübingen, Germany., Lewis RA; NPARU, University of Worcester, Worcester, UK., Böckeler M; Department of Internal Medicine VIII, Medical Oncology and Pneumology, Eberhard Karls University, Tübingen, Germany., Hetzel J; Department of Internal Medicine VIII, Medical Oncology and Pneumology, Eberhard Karls University, Tübingen, Germany.
Publikováno v:
Thoracic cancer [Thorac Cancer] 2020 Jul; Vol. 11 (7), pp. 2044-2047. Date of Electronic Publication: 2020 May 06.
Autor:
Wang X; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; Huashan Hospital, Fudan University, Shanghai, People's Republic of China., Häring MF; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; Division of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine IV, University Hospital Tuebingen, Tuebingen, Germany., Rathjen T; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; Novo Nordisk A/S, Måløv, Denmark., Lockhart SM; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; Queen's University Belfast, Belfast, UK., Sørensen D; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; Odense University Hospital, University of Southern Denmark, Odense, Denmark.; Danish Diabetes Academy, Odense, Denmark., Ussar S; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.; JRG Adipocytes and Metabolism, Institute for Diabetes and Obesity, Helmholtz Center Munich-Neuherberg, Germany.; German Center for Diabetes Research (DZD), Neuherberg, Germany., Rasmussen LM; Odense University Hospital, University of Southern Denmark, Odense, Denmark., Bertagnolli MM; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Kahn CR; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA., Rask-Madsen C; Joslin Diabetes Center and Harvard Medical School, Boston, MA, USA.
Publikováno v:
Oncogene [Oncogene] 2017 Aug 31; Vol. 36 (35), pp. 4987-4996. Date of Electronic Publication: 2017 May 01.